{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T16:19:10Z","timestamp":1648916350725},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12288-018-1056-4","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T07:09:17Z","timestamp":1544166557000},"page":"471-477","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome"],"prefix":"10.1007","volume":"35","author":[{"given":"Rania M.","family":"Bakry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebtesam M.","family":"El-Gezawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer M.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"NasrEldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid A.","family":"Nasif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EssamAbd","family":"El-Mohsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"publisher","first-page":"159813","DOI":"10.1155\/2013\/159813","volume":"2013","author":"T Wr\u00f3bel","year":"2013","unstructured":"Wr\u00f3bel T, Mazur G, Dzietczenia J, G\u0119bura K, Kuliczkowski K (2013) Bogunia-Kubik K (2013) VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma. Biomed Res Int 2013:159813. https:\/\/doi.org\/10.1155\/2013\/159813","journal-title":"Biomed Res Int."},{"key":"1056_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, (2002). CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"1056_CR3","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F GLOBOCAN (2012) v1.0. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, IARC, 2013"},{"issue":"1","key":"1056_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11\u201330","journal-title":"CA Cancer J Clin"},{"key":"1056_CR5","unstructured":"Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. (eds) (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publication No. 160. http:\/\/gco.iarc.fr"},{"key":"1056_CR6","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1093\/annonc\/mds079","volume":"23","author":"CM Herzog","year":"2012","unstructured":"Herzog CM, Dey S, Hablas A, Khaled HM, Seifeldin IA, Ramadan M, El-Hamzawy H, Wilson ML, Soliman AS (2012) Geographic distribution of hematopoietic cancers in the Nile delta of Egypt. Ann Oncol 23:2748\u20132755","journal-title":"Ann Oncol"},{"key":"1056_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE DeSantis","year":"2014","unstructured":"DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014: Cancer Treatment and Survivorship Statistics, 2014. CA A Cancer J Clin 64:252\u2013271","journal-title":"CA A Cancer J Clin"},{"key":"1056_CR8","first-page":"2041","volume":"34","author":"E Hadler-Olsen","year":"2013","unstructured":"Hadler-Olsen E, Winberg JO, Uhlin-Hansen L (2013) Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. TumourBiol 34:2041\u20132051","journal-title":"TumourBiol"},{"key":"1056_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd2945","volume":"8","author":"GS Butler","year":"2009","unstructured":"Butler GS, Overall CM (2009) Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov 8:935\u2013948","journal-title":"Nat Rev Drug Discov"},{"key":"1056_CR10","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-04-1521","volume":"64","author":"C Yu","year":"2004","unstructured":"Yu C, Zhou Y, Miao X et al (2004) Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res 64:7622\u20137628","journal-title":"Cancer Res"},{"key":"1056_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.7314\/APJCP.2015.16.2.443","volume":"16","author":"SO Sag","year":"2015","unstructured":"Sag SO, Gorukmez O, Ture M, Gorukmez O, Topak A, Sahinturk S, Ocakoglu G, Gulten T, Ali R, Yakut T (2015) MMP2 gene-735 C\/T and MMP9 gene -1562 C\/T polymorphisms in JAK2V617F positive myeloproliferative disorders. Asian Pac J Cancer Prev 16:443\u2013449","journal-title":"Asian Pac J Cancer Prev"},{"key":"1056_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/10409230701340019","volume":"42","author":"B Cauwe","year":"2007","unstructured":"Cauwe B, Van den Steen PE, Opdenakker G (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42:113\u2013185","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1056_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00432-014-1630-6","volume":"140","author":"W Shen","year":"2014","unstructured":"Shen W, Xi H, Wei B, Chen L (2014) The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis. J Cancer Res Clin Oncol 140:1003\u20131009","journal-title":"J Cancer Res Clin Oncol"},{"key":"1056_CR14","first-page":"Ra32","volume":"15","author":"A Jezierska","year":"2009","unstructured":"Jezierska A, Motyl T (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 15:Ra32\u2013Ra40","journal-title":"Med Sci Monit"},{"key":"1056_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3109\/07357901003735634","volume":"28","author":"Q Qian","year":"2010","unstructured":"Qian Q, Wang Q, Zhan P, Peng L, Wei SZ, Shi Y et al (2010) The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis. Cancer Invest 28:661\u2013669","journal-title":"Cancer Invest"},{"key":"1056_CR16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jso.21462","volume":"101","author":"MF Jagt Van der","year":"2010","unstructured":"Van der Jagt MF, Wobbes T, Strobbe LJ, Sweep FC, Span PN (2010) Metalloproteinases and their regulators in colorectal cancer. J Surg Oncol 101:259\u2013269","journal-title":"J Surg Oncol"},{"key":"1056_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.05.001","volume":"69","author":"A Gadducci","year":"2009","unstructured":"Gadducci A, Cosio S, Tana R, Genazzani AR (2009) Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol 69:12\u201327","journal-title":"Crit Rev Oncol Hematol"},{"key":"1056_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1600-0609.2007.01012.x","volume":"80","author":"E Travaglino","year":"2008","unstructured":"Travaglino E, Benatti C, Malcovati L et al (2008) Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. Eur J Haematol 80:216\u2013226","journal-title":"Eur J Haematol"},{"key":"1056_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2141.2011.08725.x","volume":"154","author":"AG Buggins","year":"2011","unstructured":"Buggins AG, Levi A, Gohil S et al (2011) Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9. Br J Haematol 154:216\u2013222","journal-title":"Br J Haematol"},{"key":"1056_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0145-2126(00)00104-1","volume":"25","author":"O Kuittinen","year":"2001","unstructured":"Kuittinen O, Savolainen ER, Koistinen P, M\u00f6tt\u00f6nen M, Turpeenniemi-Hujanen T (2001) MMP-2 and MMP-9 expression in adult and childhood acute lymphatic leukemia (ALL). Leuk Res 25:125\u2013131","journal-title":"Leuk Res"},{"issue":"5","key":"1056_CR21","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.26483","volume":"131","author":"LP Diao","year":"2012","unstructured":"Diao LP, Ma H, Wei GC, Li T, Liu HS, Liu LH, Wu LL, Zhao GM, Gao YH (2012) Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin\u2019s lymphoma. Int J Cancer 131(5):1095\u20131103","journal-title":"Int J Cancer"},{"key":"1056_CR22","first-page":"1313","volume":"93","author":"HM Gouda","year":"2014","unstructured":"Gouda HM, Khorshied MM, El Sissy MH, Shaheen IAM, Mohsen MMA (2014) Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin\u2019s lymphoma in Egyptians. Ann Hematol 93:1313\u20131318","journal-title":"Ann Hematol"},{"key":"1056_CR23","doi-asserted-by":"publisher","first-page":"805907","DOI":"10.1155\/2010\/805907","volume":"2010","author":"A Vasku","year":"2010","unstructured":"Vasku A, Vasku JB, Necas M, Vasku V (2010) Matrix Metalloproteinase-2 promoter genotype as a marker of cutaneous T-cell lymphoma early stage. J Biomed Biotechnol 2010:805907","journal-title":"J Biomed Biotechnol"},{"key":"1056_CR24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/carcin\/bgi057","volume":"26","author":"Y Zhou","year":"2005","unstructured":"Zhou Y, Yu C, Miao X, Wang Y, Tan W, Sun T, Zhang X, Xiong P, Lin D (2005) Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancersusceptibility. Carcinogenesis 26:1117\u20131121","journal-title":"Carcinogenesis"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.lungcan.2006.11.021","volume":"56","author":"J Rollin","year":"2007","unstructured":"Rollin J, R\u00e9gina S, Vourc\u2019h P, Iochmann S, Bl\u00e9chet C, Reverdiau P, Gruel Y (2007) Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Lung Cancer 56:273\u2013280","journal-title":"Lung Cancer"},{"key":"1056_CR26","first-page":"3987","volume":"63","author":"X Miao","year":"2003","unstructured":"Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, Lin D (2003) A functional polymorphism in the matrix metalloproteinase-2 gene promoter (\u2212\u20091306C\/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 63:3987\u20133990","journal-title":"Cancer Res"},{"key":"1056_CR27","first-page":"3820","volume":"8","author":"G Ghilardi","year":"2002","unstructured":"Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R (2002) A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 8:3820\u20133823","journal-title":"Clin Cancer Res"},{"issue":"3\u20134","key":"1056_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/10428190009089428","volume":"37","author":"T Kelly","year":"2000","unstructured":"Kelly T, Borset M, Abe E et al (2000) Matrix metalloproteinases in multiple myeloma. Leuk Lymphoma 37(3\u20134):273\u2013281","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"1056_CR29","doi-asserted-by":"publisher","first-page":"L386","DOI":"10.1152\/ajplung.00193.2005","volume":"291","author":"KH Thomas","year":"2006","unstructured":"Thomas KH, Myen P, Suttorp N (2006) Single nucleotide polymorphismin 5\u2032-flankingregion reduces transcription of surfactant protein B gene in H441 cells. Am J Physiol Lung Cell Mol Physiol 291(3):L386\u2013L390","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"1056_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/01.ATV.15.1.58","volume":"15","author":"BR Zysow","year":"1995","unstructured":"Zysow BR, Lindahl GE, Wade DP, Knight BL, Lawn RM (1995) C\/T polymorphism in the 5\u2032 untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb Vasc Biol 15(1):58\u201364","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-018-1056-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-018-1056-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-018-1056-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T01:55:57Z","timestamp":1605578157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-018-1056-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s12288-018-1056-4","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"24 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}